8 transactions in one company, from February 20, 2026 to March 19, 2026.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| AN2 Therapeutics, Inc. | ANTX | 8 | — | — |
8 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | ANTX | Eric EasomCEODERIV | Mar 19 | D | 267,650 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Eric EasomCEODERIV | Mar 19 | A | 267,650 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Eric EasomCEODERIV | Mar 19 | D | 225,000 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Eric EasomCEODERIV | Mar 19 | A | 225,000 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Eric EasomCEODERIV | Mar 19 | D | 249,999 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Eric EasomCEODERIV | Mar 19 | A | 249,999 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Eric EasomCEODERIV | Feb 20 | A | 224,500 | $0.00 | —? |
| AN2 Therapeutics, Inc. | ANTX | Eric EasomCEO | Feb 20 | A | 112,250 | $0.00 | — |